BOULDER, Colo., Aug. 28, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the 2017 Wells Fargo Healthcare Conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
|
Event: |
Wells Fargo Healthcare Conference |
|
Presenter: |
Ron Squarer, Chief Executive Officer |
|
Date: |
Wednesday, September 6, 2017 |
|
Time: |
9:05 a.m. Eastern Time |
|
Webcast: |
https://cc.talkpoint.com/well001/090617a_as/?entity=65_KJWP5P3 |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).
|
CONTACT: |
Tricia Haugeto |
|
Array BioPharma Inc. | |
|
303-386-1193 | |
SOURCE Array BioPharma Inc.